Register for real-time alerts, custom portfolio, and market movers

Get Started

VRDN Viridian Therapeutics Inc

14.25

0.00 (0.00%)

Apr 23 2024 - Closed

Delayed by 15 minutes

Viridian files application with US FDA to begin trial of VRDN-002 for eye disease

To read the full story on Seeking Alpha, click here.

Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Viridian Therapeutics Charts.

Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Viridian Therapeutics Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Viridian Therapeutics Inc News

More Viridian Therapeutics Inc News Articles

Bell Buckle (PK)

Valiant Eagle (PK)

Ubiquitech Software (PK)

Voip Pal Com (QB)

Elite Pharmaceuticals (QB)

Intergrated Cannabis Sol... (PK)

MicroCloud Hologram

Moon Equity (PK)

Rennova Health (PK)

Delayed Upgrade Clock